A PI3K- and GTPase-independent Rac1-mTOR mechanism mediates MET-driven anchorage-independent cell growth but not migration
- 23 June 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 13 (637)
- https://doi.org/10.1126/scisignal.aba8627
Abstract
Receptor tyrosine kinases (RTKs) are often overexpressed or mutated in cancers and drive tumor growth and metastasis. In the current model of RTK signaling, including that of MET, downstream phosphatidylinositol 3-kinase (PI3K) mediates both cell proliferation and cell migration, whereas the small guanosine triphosphatase (GTPase) Rac1 mediates cell migration. However, in cultured NIH3T3 and glioblastoma cells, we found that class I PI3K mediated oncogenic MET–induced cell migration but not anchorage-independent growth. In contrast, Rac1 regulated both processes in distinct ways. Downstream of PI3K, Rac1 mediated cell migration through its GTPase activity, whereas independently of PI3K, Rac1 mediated anchorage-independent growth in a GTPase-independent manner through an adaptor function. Through its RKR motif, Rac1 formed a complex with the kinase mTOR to promote its translocation to the plasma membrane, where its activity promoted anchorage-independent growth of the cell cultures. Inhibiting mTOR with rapamycin suppressed the growth of subcutaneous MET-mutant cell grafts in mice, including that of MET inhibitor–resistant cells. These findings reveal a GTPase-independent role for Rac1 in mediating a PI3K-independent MET-to-mTOR pathway and suggest alternative or combined strategies that might overcome resistance to RTK inhibitors in patients with cancer.Keywords
Funding Information
- Bayer
- Breast Cancer Now (2008NovPR10)
- Pancreatic Cancer Research Fund
- Medical Research Council
- Medical Research Council (MR/R009732/1)
- Cancer Research UK (C236/A11795)
- Barts and The London School of Medicine and Dentistry (RAB 05/PJ/07)
- Cancer Research UK (C309/A11566)
- Rosetrees Trust (M314)
- Rosetrees Trust (M346)
- Cancer Research UK (C309/A11566)
This publication has 77 references indexed in Scilit:
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase IsoformsCell, 2013
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastomaProceedings of the National Academy of Sciences of the United States of America, 2011
- Phosphatidylinositol 3-Kinase: The OncoproteinCurrent Topics in Microbiology and Immunology, 2010
- Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino AcidsCell, 2010
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Endocytic Trafficking of Rac Is Required for the Spatial Restriction of Signaling in Cell MigrationCell, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Exploring the specificity of the PI3K family inhibitor LY294002Biochemical Journal, 2007
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006